You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國同輻(01763.HK)與核工業總醫院簽訂戰略合作框架協議
格隆匯 08-14 21:50

格隆匯 8 月 14日丨中國同輻(01763.HK)宣佈,於2020年8月13日,公司與核工業總醫院簽訂戰略合作框架協議。

根據該協議,雙方將在學科建設、科技創新、人才培養、國際合作等方面開展深度合作,充分發揮雙方優勢,實現互利共贏、共同發展。中國同輻將利用自身優勢,積極參與核工業總醫院新成立的"核素診療中心"與"核技術臨牀研究中心"建設,圍繞核素診療新產品與新技術、核技術臨牀應用轉化等方面開展合作研究與聯合攻關,共同推動我國核技術應用和核特色醫療整體水平提升

核工業總醫院是一所集醫療、教學、科研、預防、核應急等為一體的三級甲等醫院。是國家藥物臨牀試驗基地、國家住院醫師規範化培訓基地、國家核應急醫學救援基地、國家級卒中中心、國家級胸痛中心。建有放射醫學與輻射防護國家重點實驗室臨牀中心、放射醫學轉化中心,7個市級重點實驗室、4個大學臨牀研究所以及與國內多中心合作的平台。與法國、美國、日本、以色列等廣泛深入合作。

中國同輻是中國核工業集團有限公司控股子公司,是中核集團核技術應用專業化公司,業務覆蓋放射源生產、放射性藥品生產、工業輻照應用、醫學診斷、核醫療裝備研發╱服務、核素製造、進出口貿易等領域。

此次雙方合力打通核技術應用中的核特色醫療前端和應用產業鏈,攜手打造國內一流、國際知名的核技術醫學應用基礎-臨牀一體化平台,為公司核技術應用人才培養、科技創新、產業發展提供了重要支撐。雙方能夠優勢互補,開拓創新,共同建設引領創新、輻射發展、具有影響力的中心,點燃核技術應用產業高質量發展新引擎。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account